10-12 September 2018 //  Lancaster Royal Hotel, London


Tom Payne

Dr Tom Payne

Chief Technology Officer, Oxford Genetics

Tom has more than 10 years commercial experience in biopharmaceutical development and bioproduction, having held R&D and commercially-focused roles at both Novozymes Biopharma (now Albumedix) and Lonza in the UK. At Oxford Genetics, Tom is responsible for technology development activities, spanning the breadth of services and products offered. His research interests include gene editing, synthetic biology and cellular engineering. Tom holds a BSc and Ph.D in Molecular Biology from the University of Nottingham.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad